Morgan Stanley analyst Joe Laetsch raised the firm's price target on ProFrac Holding to $5 from $4 and keeps an Underweight rating on the shares. The firm raised its 2027 and 2028 revenues estimates 1% and 2% and its adjusted EBITDA forecasts 8% and 7%, respectively, after factoring Q4 results and 2026 guidance. However, it still currently sees more attractive risk-reward elsewhere in its coverage, the analyst tells investors.
